Breaking News Instant updates and real-time market news.

SWDAF

Software AG

$0.00 /

+ (+0.00%)

19:33
10/17/19
10/17
19:33
10/17/19
19:33

Software AG upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs analyst Gautam Pillai upgraded Software AG to Buy with a price target of EUR36.

SWDAF Software AG
$0.00 /

+ (+0.00%)

07/25/19 Morgan Stanley
Software AG upgraded to Equal Weight from Underweight at Morgan Stanley
06/07/19 Credit Suisse
Software AG upgraded to Neutral from Underperform at Credit Suisse

TODAY'S FREE FLY STORIES

Earnings
Nautilus reports Q4 EPS 12c, consensus (14c) » 16:10
02/24/20
02/24
16:10
02/24/20
16:10
NLS

Nautilus

$3.20 /

-0.31 (-8.84%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Keysight Technologies sees Q2 revenue $1.138B-$1.178B, consensus $1.15B  16:10
02/24/20
02/24
16:10
02/24/20
16:10
KEYS

Keysight Technologies

$90.93 /

-5.26 (-5.47%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Keysight Technologies sees Q2 revenue $1.138B-$1.178B, consensus $1.15B  16:10
02/24/20
02/24
16:10
02/24/20
16:10
KEYS

Keysight Technologies

$90.93 /

-5.26 (-5.47%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Theravance Biopharma sees FY20 operating loss ($225M)-($205M)  16:10
02/24/20
02/24
16:10
02/24/20
16:10
TBPH

Theravance Biopharma

$23.67 /

-2.04 (-7.93%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Kratos Defense CEO comments on unmanned programs » 16:10
02/24/20
02/24
16:10
02/24/20
16:10
KTOS

Kratos Defense

$19.22 /

-1.01 (-4.99%)

Eric DeMarco,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Gaia reports Q4 EPS (15c), consensus (19c) » 16:10
02/24/20
02/24
16:10
02/24/20
16:10
GAIA

Gaia

$10.28 /

+0.26 (+2.59%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Itron reports Q4 EPS 72c, consensus 53c » 16:10
02/24/20
02/24
16:10
02/24/20
16:10
ITRI

Itron

$78.26 /

-6.82 (-8.02%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Keysight Technologies reports Q4 EPS $1.26, consensus $1.07 » 16:10
02/24/20
02/24
16:10
02/24/20
16:10
KEYS

Keysight Technologies

$90.93 /

-5.26 (-5.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Theravance Biopharma reports Q4 EPS ($1.17), consensus ($1.13) » 16:09
02/24/20
02/24
16:09
02/24/20
16:09
TBPH

Theravance Biopharma

$23.79 /

-1.92 (-7.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Tandem Diabetes sees FY20 revenue $450M-$465M, consensus $444.62M » 16:09
02/24/20
02/24
16:09
02/24/20
16:09
TNDM

TNDM

/

+

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
AxoGen backsFY20 revenue view of $124M-$128M, consensus $131.75M  16:09
02/24/20
02/24
16:09
02/24/20
16:09
AXGN

AxoGen

$14.70 /

+ (+0.00%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Tandem Diabetes reports Q4 EPS 4c, consensus (5c) » 16:09
02/24/20
02/24
16:09
02/24/20
16:09
TNDM

TNDM

/

+

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Shake Shack sees FY20 revenue $712M-$720M, consensus $737.1M » 16:08
02/24/20
02/24
16:08
02/24/20
16:08
SHAK

Shake Shack

$73.86 /

-0.925 (-1.24%)

Sees FY20 same-shack…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Kratos Defense sees Q1 as lowest quarter of fiscal year » 16:08
02/24/20
02/24
16:08
02/24/20
16:08
KTOS

Kratos Defense

$19.23 /

-1.005 (-4.97%)

Kratos' FY20 initial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
LSB Industries reports Q4 EPS ($1.30), one estimate (97c) » 16:08
02/24/20
02/24
16:08
02/24/20
16:08
LXU

LSB Industries

$2.27 /

-0.15 (-6.20%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Earnings
Arlo Technologies sees Q1 EPS (33c)-(36c), consensus (29c) » 16:08
02/24/20
02/24
16:08
02/24/20
16:08
ARLO

Arlo Technologies

$3.32 /

-0.095 (-2.78%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Heidrick & Struggles reports Q4 EPS 54c, consensus 54c » 16:08
02/24/20
02/24
16:08
02/24/20
16:08
HSII

Heidrick & Struggles

$25.99 /

-1.4 (-5.11%)

Reports Q4 revenue $180M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
AxoGen reports Q4 EPS (10c), consensus (9c) » 16:07
02/24/20
02/24
16:07
02/24/20
16:07
AXGN

AxoGen

$14.70 /

+ (+0.00%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Orthofix sees Q1 adjusted EPS 9c-12c, consensus 32c » 16:07
02/24/20
02/24
16:07
02/24/20
16:07
OFIX

Orthofix

$44.85 /

-0.08 (-0.18%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Shake Shack CEO sees 2020 as another year of 'strong unit growth' » 16:07
02/24/20
02/24
16:07
02/24/20
16:07
SHAK

Shake Shack

$73.86 /

-0.925 (-1.24%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Orthofix sees FY20 adjusted EPS $1.00-$1.10, consensus $1.70 » 16:07
02/24/20
02/24
16:07
02/24/20
16:07
OFIX

Orthofix

$44.85 /

-0.08 (-0.18%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Arlo Technologies reports Q4 EPS (26c), consensus (31c) » 16:07
02/24/20
02/24
16:07
02/24/20
16:07
ARLO

Arlo Technologies

$3.33 /

-0.085 (-2.49%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Cue Biopharma initiated with an Outperform at Oppenheimer » 16:07
02/24/20
02/24
16:07
02/24/20
16:07
CUE

Cue Biopharma

$18.66 /

-1.1 (-5.57%)

Oppenheimer analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Shake Shack reports Q4 EPS (6c), consensus 0c » 16:06
02/24/20
02/24
16:06
02/24/20
16:06
SHAK

Shake Shack

$73.91 /

-0.875 (-1.17%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Retrophin reports Q4 EPS (70c), consensus (64c) » 16:06
02/24/20
02/24
16:06
02/24/20
16:06
RTRX

Retrophin

$16.70 /

-0.58 (-3.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.